Petros Pharmaceuticals, Inc. Contract with Customer, Refund Liability, Current
Petros Pharmaceuticals, Inc. (PTPI) had Contract with Customer, Refund Liability, Current of $5.20 million as of 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes
us-gaap:ContractWithCustomerRefundLiabilityCurrent · last filed 2025-03-31
- 2024-12-31: Contract with Customer, Refund Liability, Current $5.20M.
- 2024-09-30: Contract with Customer, Refund Liability, Current $5.30M.
- 2024-06-30: Contract with Customer, Refund Liability, Current $4.90M.
- 2024-03-31: Contract with Customer, Refund Liability, Current $4.60M.
| Period end | Contract with Customer, Refund Liability, Current |
|---|---|
| 2024-12-31 | $5.20M 10-K · filed 2025-03-31 |
| 2024-09-30 | $5.30M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $4.90M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.60M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $4.20M 10-K · filed 2025-03-31 |
| 2023-09-30 | $2.90M 10-Q · filed 2023-11-15 |
| 2023-06-30 | $2.60M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.20M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.30M 10-K · filed 2024-04-01 |
| 2022-09-30 | $3.50M 10-Q/A · filed 2022-11-15 |
| 2022-06-30 | $3.00M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $3.80M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $3.80M 10-Q · filed 2023-11-15 |
| 2021-09-30 | $3.20M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $5.70M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $7.00M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $7.10M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |